The latest: Medical infusion products maker PW Medtech Group Ltd. (1358.HK) announced it will acquire 51% of Sichuan Ruijian Medical Technology Co. Ltd., another medical device maker, for a cash consideration of $99.46 million.

Looking up: Sichuan Ruijian develops, manufactures and sells blood purification equipment. PW Medtech will expand its product portfolio through the acquisition and take a step into the blood purification market.

Take Note: Lepu Medical will remain a shareholder of Sichuan Ruijian with 18% of the company. Lepu Medical is controlled by Pu Zhongjie, husband of PW Medtech executive director Zhang Yue’e, meaning the acquisition constitutes a connected transaction.

Digging Deeper: PW Medtech’s revenue and profit have fluctuated in the last five years. Affected by the Covid-19 epidemic, the company’s revenue dropped by 31.7% to 247 million yuan ($38.8 million) last year. The group has said that Chinese government policies have accelerated development of the country’s domestic medical device industry, providing it with future growth opportunities. Through this acquisition, PW Medtech will obtain R&D expertise, experience and a future product pipeline in the field of blood purification. Sichuan Ruijian had a pre-tax profit of 73.89 million yuan last year, which should help to stabilize PW Medtech’s own revenue and profits.

Market Reaction: PW Medtech’s stock jumped by 10% on Wednesday morning after the news was announced, and was up 5.6% at HK$1.13 at the midday trading break.

Translation by Jony Ho

To subscribe to Bamboo Works free weekly newsletter, click here

Recent Articles

Yalla gaming revenue jumps

Yalla profit zooms on gaming jump, enhanced efficiency

The Middle Eastern social media company posted record revenue in the third quarter, as its profit jumped 44% on cost controls and strong gaming revenue gains      Yalla’s revenue rose 6.4%…
ZTO underperformed quarter-on-quarter despite robust year-on-year gains

ZTO momentum slows in third quarter as headwinds build

The delivery company’s revenue and profit both rose year-on-year despite China’s economic slowdown, but both figures were down from the second quarter Key Takeaways: ZTO earned 2.35 billion yuan in…
Illustration of the coming back Chinese Yuan, Renminbi

CHINA BULLETIN: Yuan on the Comeback Trail

In this week’s issue the yuan bounces back, a lifeline for developers and a livestreamer confirms its CEO’s arrest. On a scale of 1 to 100, we give the week…